Fibrinolysis Inhibiting Factor is a peptide motif associated with regulation of fibrin-binding and protease interaction surfaces. Its sequence supports mapping of hydrophobic and charged residues involved in complex formation. Researchers examine conformational preferences for mechanistic insight. The molecule aids in defining motifs that stabilize fibrin-rich matrices.
CAT No: F02039
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Myotropic activity of allatostatins in tenebrionid beetles
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More